AstraZeneca's own project team collaborated with main architects Lovelock, Mitchell, and Partners to create the central atrium, which serves as a multi-functional open space. And when it came time to choose the slate, Broughton Moor from Burlington Slate, Ltd. of Kirkby-in-Furness, Cumbria, England, was selected. The stone is featured throughout the main reception area and perimeters of the central atrium, and it was specified with a honed finish. Leading Cheshire-based interior designers, Claremont Business Environments, specified the stone. â€œThe look of the atrium and indeed of the whole building is sleek and modern and offers several innovative features,â€ said Simon Harris, senior designer at Claremont Business Environments. The atrium features include reception and relaxation areas, and a cafe.
The slate was chosen to provide a contrast to the York stone -- a popular paving stone in the U.K. -- that is also featured throughout the large atrium. â€œOn such a prestigious project, it was critical that we incorporated materials of the highest standard, so given the superior quality of Burlington stone and its intrinsic beauty, it was an obvious choice,â€ said Harris.
In order to meet the goal of providing a more open atmosphere and flexible working methods, architects constructed the building in an open plan environment. Each floorplate has a core support facility providing meeting rooms of varying sizes, a breakout area, and an exhibition and presentation space.
â€œWe are extremely pleased with the final result -- it is a great design and professionally implemented. The whole building is superb,â€ said Andrew Shore, a spokesperson from AstraZeneca.
Recently, the projects design received the British Council for Offices (BCO) 2003 Regional Award for the corporate workplace for North of England, North Wales and Northern Ireland.